Position in TRLV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$245,750
New position
Shares Held
25,000
first reported quarter
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 31 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BURNEY CO/ holds $12,528,479 across 7 Drug Manufacturers - Specialty & Generic names. TRLV ranks #6 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
10,588 | $5,736,896 | |
| 2 | LQDA |
Liquidia Corp
|
53,008 | $4,226,327 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
6,201 | $1,045,116 | |
| 4 | VTRS |
Viatris Inc
|
49,456 | $785,361 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
6,090 | $287,874 | |
| 6 | TRLV |
Trulieve Cannabis Corp.
This page
|
25,000 | $245,750 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
4,325 | $201,155 |
All Filings in TRLV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $245,750 | 25,000 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||